Understanding how certain genetic variants lead to chronic pancreatitis

Pathophysiology of Chronic Pancreatitis Associated with Misfolded PNLIP Risk Variants

NIH-funded research Washington University · NIH-11000276

This study is looking at how certain gene changes might make some people more likely to develop chronic pancreatitis, and it aims to find ways to help fix the problems caused by these gene changes to prevent the disease from getting worse.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University NIH-funded
Lab location1 site (Saint Louis, United States)
Project IDNIH-11000276 on NIH RePORTER

What this research studies

This research investigates the role of specific genetic variants in the pancreatic triglyceride lipase (PNLIP) gene that may increase the risk of developing chronic pancreatitis. The study focuses on how misfolded proteins from these variants contribute to the disease, particularly through mechanisms that cause cellular stress and inflammation in the pancreas. By using a pre-clinical model that mimics human conditions, the researchers aim to uncover the underlying processes that lead to recurrent acute pancreatitis and chronic disease progression. The ultimate goal is to identify potential therapeutic strategies to restore normal protein function and prevent disease advancement.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a genetic predisposition to chronic pancreatitis, particularly those with known PNLIP variants.

Not a fit: Patients without genetic variants associated with PNLIP or those who do not have chronic pancreatitis may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent or slow the progression of chronic pancreatitis in patients with specific genetic risk factors.

How similar studies have performed: While the specific approach of targeting misfolded PNLIP variants is novel, similar research has shown promise in understanding genetic contributions to other forms of pancreatitis.

Where this research is happening

Saint Louis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.